Boesenberols, Pimarane Diterpenes with TRAIL-Resistance-Overcoming Activity from Boesenbergia pandurata

Journal of Natural Products

Volumn 79, Issue 8, 2016, Pages 2075-2082

  Karmakar, Utpal K ^a,b   Ishikawa, Naoki ^a   Arai, Midori A ^a   Ahmed, Firoj ^a,c   Koyano, Takashi ^d   Kowithayakorn, Thaworn ^e   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KHULNA UNIVERSITY   (Bangladesh)

^c UNIVERSITY OF DHAKA   (Bangladesh)

^d Temko Corporation   (Japan)

^e KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BOESENBERGIA PANDURATA EXTRACT; BOESENBEROL A; BOESENBEROL B; BOESENBEROL C; BOESENBEROL D; BOESENBEROL DERIVATIVE; BOESENBEROL E; BOESENBEROL F; BOESENBEROL G; BOESENBEROL H; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DITERPENE; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; LUTEOLIN; PIMARANE DERIVATIVE; PLANT EXTRACT; PROTEIN BAK; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; ABIETANE DERIVATIVE; APOPTOSIS REGULATORY PROTEIN; TERPENE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; BIOASSAY; BOESENBERGIA PANDURATA; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ISOLATION; FRACTIONATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; MEDICINAL PLANT; NONHUMAN; RHIZOME; UPREGULATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; THAILAND; ZINGIBERACEAE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CELL SURVIVAL; DITERPENES, ABIETANE; HEK293 CELLS; HUMANS; MOLECULAR STRUCTURE; MONOTERPENES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RHIZOME; THAILAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; ZINGIBERACEAE;

EID: 84984704748     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/acs.jnatprod.6b00424     Document Type: Article

References (27)

1. Trivedi, R.; Mishra, D. P. Front. Oncol. 2015, 5, 1-20 10.3389/fonc.2015.00069
2. Hellwig, C. T.; Rehm, M. Mol. Cancer Ther. 2012, 11, 3-13 10.1158/1535-7163.MCT-11-0434
3. Ahmed, F.; Ishibashi, M. Chem. Pharm. Bull. 2016, 64, 119-127 10.1248/cpb.c15-00732
4. Wu, G. S. Cancer Lett. 2009, 285, 1-5 10.1016/j.canlet.2009.02.029
5. Amarante-Mendes, G. P.; Griffith, T. S. Pharmacol. Ther. 2015, 155, 117-131 10.1016/j.pharmthera.2015.09.001
6. Yang, J. F.; Cao, J. G.; Tian, L.; Liu, F. Cancer Chemother. Pharmacol. 2012, 69, 195-206 10.1007/s00280-011-1686-9
7. Piggott, L.; Omidvar, N.; Perez, S. M.; Eberl, M.; Clarkson, R. W. Breast Cancer Res. 2011, 13, 2-15 10.1186/bcr2945
8. Lindhagen, E.; Nygren, P.; Larsson, R. Nat. Protoc. 2008, 3, 1364-1369 10.1038/nprot.2008.114
9. Chahyadi, A.; Hartati, R.; Wirasutisna, K. R.; Elfahmi Procedia Chem. 2014, 13, 13-37 10.1016/j.proche.2014.12.003
10. Elfahmi; Woerdenberg, H. J.; Kayse, O. J. Herb. Med. 2014, 4, 51-73 10.1016/j.hermed.2014.01.002
11. Prawat, U.; Tuntiwachwuttikul, P.; Taylor, W. C.; Engelhard, T.; Skelton, B. W.; White, A. H. Phytochemistry 1993, 32, 991-997 10.1016/0031-9422(93)85242-J
12. Win, N. N.; Ito, T.; Aimaiti, S.; Imagawa, H.; Ngwe, H.; Abe, I.; Morita, H. J. Nat. Prod. 2015, 78, 1113-1118 10.1021/acs.jnatprod.5b00108
13. Tuchinda, P.; Udchachon, J.; Reutrakul, V.; Santisuk, T.; Skelton, B. W.; White, A. H.; Taylor, W. C. Phytochemistry 1994, 36, 731-734 10.1016/S0031-9422(00)89806-4
14. Thongnest, S.; Mahidol, C.; Sutthivaiyakit, S.; Ruchirawat, S. J. Nat. Prod. 2005, 68, 1632-1636 10.1021/np050186l
15. Liu, X.; Wu, Q.-X.; Shi, Y.-P. J. Chin. Chem. Soc. 2005, 52, 369-374 10.1002/jccs.200500055
16. Meragelman, T. L.; Silva, G. L.; Mongelli, E.; Gil, R. R. Phytochemistry 2003, 62, 569-572 10.1016/S0031-9422(02)00611-8
17. Wu, X.-D.; Zhang, L.-C.; He, J.; Li, G.-T.; Ding, L.-F.; Gao, X.; Dong, L.-B.; Song, L.-D.; Li, Y.; Zhao, Q.-S. J. Asian Nat. Prod. Res. 2013, 15, 151-157 10.1080/10286020.2012.757596
18. Huang, W.; Zhang, P.; Jin, Y.-C.; Shi, Q.; Cheng, Y.-Y.; Qu, H.-B.; Ma, Z.-J. Helv. Chim. Acta 2008, 91, 944-950 10.1002/hlca.200890100
19. Zhao, J.; Lu, Y.; Shen, H. M. Cancer Lett. 2012, 314, 8-23 10.1016/j.canlet.2011.09.040
20. Gupta, S. C.; Sajin, F. K.; Nair, M. S.; Mo, Y. Y.; Aggarwal, B. B. J. Biol. Chem. 2013, 288, 32343-32356 10.1074/jbc.M113.455188
21. Yang, J. F.; Cao, J. G.; Tian, L.; Liu, F. Cancer Chemother. Pharmacol. 2012, 69, 195-206 10.1007/s00280-011-1686-9
22. Liabo, X.; Zhang, L.; Thrasher, B. Mol. Cancer Ther. 2003, 2, 1215-1222
23. Prasad, S.; Yadav, V. R.; Ravindran, J.; Aggarwal, B. B. Cancer Res. 2011, 71, 538-549 10.1158/0008-5472.CAN-10-3121
24. Park, E. H.; Kim, Y. J.; Yamabe, N.; Park, S. H.; Kim, H. K.; Jang, H. J.; Kim, J. H.; Cheon, G. J.; Ham, J.; Kang, K. S. J. Ginseng Res. 2014, 38, 22-27 10.1016/j.jgr.2013.11.007
25. Wu, B.; Zhang, Q.; Shen, W.; Zhu, J. Mol. Cell. Biochem. 2008, 313, 125-132 10.1007/s11010-008-9749-x
26. Miki, H.; Nakamura, S.; Oda, A.; Amachi, R.; Watanabe, K.; Hanson, D.; Teramachi, J.; Hiasa, M.; Yagi, H.; Sogabe, K.; Takahashi, M.; Maruhashi, T.; Udaka, K.; Harada, T.; Fuji, S.; Nakano, A.; Ri, K. M.; Iida, S.; Ozaki, S.; Matsumoto, T.; Abe, M. Int. J. Myelom. 2015, 5, 1-7
27. Ohtsuki, T.; Tamaki, M.; Toume, K.; Ishibashi, M. Bioorg. Med. Chem. 2008, 16, 1756-1763 10.1016/j.bmc.2007.11.022